Current Value of Holding

$4.89 Million

Shares

439 Thousand

% of Portfolio

0.00%

Average Buy Price

$9.41

Avg closing price
Price range

34 Ken Griffin Theravance Biopharma Trades

Ken Griffin acquired 439 Thousand Theravance Biopharma shares worth $4.89 Million. That's 0.00% of their equity portfolio (1659th largest holding). The first Theravance Biopharma trade was made in Q2 2014. Since then Ken Griffin bought shares 34 more times and sold shares on 36 occasions. The stake costed the investor $4.13 Million, netting the investor a gain of 19% so far.

Avg closing price
Price range
Increased shares by 39.4% (+124 Thousand shares) Q1 2025
Avg closing price $9.30
Price range $8.44 - $10.47
Increased shares by 34.1% (+80.1 Thousand shares) Q4 2024
Avg closing price $9.12
Price range $7.93 - $10.08
Sold 3.9% shares (-9.46 Thousand shares) Q3 2024
Avg closing price $8.65
Price range $7.66 - $10.25
Increased shares by 110.7% (+128 Thousand shares) Q2 2024
Avg closing price $9.03
Price range $8.29 - $9.92
Sold 22.9% shares (-34.3 Thousand shares) Q1 2024
Avg closing price $9.27
Price range $8.22 - $11.59
Increased shares by 308.8% (+113 Thousand shares) Q4 2023
Avg closing price $10.06
Price range $8.58 - $11.40
Sold 54.7% shares (-44.3 Thousand shares) Q3 2023
Avg closing price $9.65
Price range $8.38 - $10.44
Increased shares by 23.5% (+15.4 Thousand shares) Q2 2023
Avg closing price $11.04
Price range $10.16 - $11.92
Sold 22.3% shares (-18.8 Thousand shares) Q1 2023
Avg closing price $10.57
Price range $9.87 - $11.44
Sold 66.3% shares (-166 Thousand shares) Q4 2022
Avg closing price $10.51
Price range $9.65 - $11.34
Increased shares by 1474.3% (+235 Thousand shares) Q3 2022
Avg closing price $9.37
Price range $8.39 - $10.22
Sold 3.8% shares (-635 shares) Q2 2022
Avg closing price $9.21
Price range $8.41 - $10.34
Increased shares by 55.4% (+5.9 Thousand shares) Q1 2022
Avg closing price $9.80
Price range $8.33 - $12.96
New holding (+10.6 Thousand shares) Q4 2021
Avg closing price $8.72
Price range $7.42 - $11.05
Sold -149 Thousand shares Q1 2021
Avg closing price $19.01
Price range $16.57 - $21.08
Sold 13.0% shares (-22.2 Thousand shares) Q3 2020
Avg closing price $18.73
Price range $14.78 - $22.49
Increased shares by 735.9% (+151 Thousand shares) Q2 2020
Avg closing price $25.69
Price range $20.64 - $30.69
Sold 4.4% shares (-948 shares) Q1 2020
Avg closing price $25.03
Price range $17.84 - $31.21
New holding (+21.4 Thousand shares) Q4 2019
Avg closing price $19.43
Price range $16.12 - $25.89
Sold -17.4 Thousand shares Q3 2019
Avg closing price $20.20
Price range $16.51 - $23.78

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!